Harlequin BX4 is a CBD-rich medical marijuana strain that delivers a consistent THC:CBD ratio of 1:1 within a range of 7% - 12%. Where cannabis is legal for medical applications patients have reacted enthusiastically to this strain which has a plethora of benefits for those in need.

It is quite a fast-flowering strain which is of great benefit with strains that are high in CBD as it is prone to degrade faster than THC; at 10 weeks of flowering CBD levels for Harlequin BX4 are around 7% whereas at 8 weeks tests reveal CBD levels of up to 12%! This strain has now been successfully stabilised and made available in seed form instead of clones (cuttings). It exudes a rich, musky, sweet pineapple perfume and has an utterly delicious flavour of Nepalese blond hashish and berries.

Among its indications for patients are pain, stress, nausea, headaches, inflammation and muscle spasms.